Lonza | LONN - Pre Tax Profit


Lonza reported CHF624M in Pre-Tax Profit for its fiscal semester ending in December of 2024.





Pre Tax Profit Change Date
Akzo Nobel EUR 148M 598M Mar/2026
Alcon AG USD 240M 24M Mar/2026
Almirall EUR 30.32M 22M Dec/2025
AstraZeneca USD 4.81B 894M Jun/2026
BASF EUR 1.1B 25M Mar/2026
Bayer EUR 2.99B 6.36B Mar/2026
Beiersdorf EUR 408.5M 43.5M Jun/2025
Covestro EUR -353M 344M Dec/2025
Demant DKK 1.64B 173M Dec/2025
Fresenius EUR 535M 42M Jun/2026
Fresenius Medical Care EUR 340M 168.46M Mar/2026
Geberit CHF 115.3M 73M Dec/2024
Genmab DKK 295M 221M Jun/2026
Givaudan CHF 642M 292M Dec/2024
GlaxoSmithKline GBP 2.68B 532M Jun/2026
GN Store Nord DKK 450M 332M Dec/2025
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Johnson Matthey GBP 110M 91M Dec/2025
Merck EUR 869M 468M Mar/2026
Novartis USD 4.27B 430M Jun/2026
Philips EUR 546M 356M Jun/2026
Roche Holding CHF 11.17B 6.38B Jun/2026
Sanofi EUR 837M 1.17B Jun/2026
Sika AG CHF 738.8M 80.1M Jun/2025
Smith & Nephew USD 469M 70M Dec/2025
Solvay EUR 40M 2M Jun/2026
UCB EUR 789M 427M Jun/2025